Events Speakers Talks
 

Speakers

Sort by
Newest
Trending
1-30 of 145
1-30 of 145
Filter
Debra Smith-Torrence
CEO and Founder at Auspicious Wellness CBD Products and Distribution
agriculture, authorize.net, bill (law), cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, celebrity, chromatography, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug enforcement administration, drug test, facebook, food, food and drug administration, good manufacturing practice, health food, hemp, indiana general assembly, instagram, irrigation, karen tallian, knowledge, license, linkedin, medical cannabis, mind, nutraceutical, pharmaceutical industry, placebo-controlled study, qr code, reading (legislature), reason, research, science, target audience, terpene, tetrahydrocannabinol, the new york times, united states senate, veto, water, youtube
Colby Watkins
COO at WherezHemp
absorption (pharmacology), alternative medicine, amazon (company), anti-inflammatory, anti-predator adaptation, appetite, aromatherapy, audit, bank, behavior, blog, blood alcohol content, book, botany, brand, brand loyalty, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, chemical substance, coffee, coffee bean, coffeehouse, communication, communication protocol, community, competition, customer relationship management, dose (biochemistry), drink, due diligence, email, email spam, emerging market, entourage effect, essential oil, facebook, food, food and drug administration, globalization, gluten-free diet, good manufacturing practice, google, hemp, herbal distillate, hindsight bias, insurance, juice, lemon, ligand (biochemistry), limonene, linkedin, mango, margin of error, medication, nsf international, nutraceutical, opt-in email, organic certification, pain, peer-to-peer, price, reason, red bull, regulatory compliance, risk management, sales, sales process engineering, secondary metabolite, social media, software , solvent, spectrum, starbucks, target corporation, telecommuting, terpene, terpenoid, tetrahydrocannabinol, trade, walmart, water, water activity, youtube
Michael Flemmens
VP of Technical Business Development at SōRSE Technology
absorption (pharmacology), alternative medicine, anti-predator adaptation, appetite, attention, blinded experiment, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis industry, chemical substance, clinicaltrials.gov, coffee, coffee bean, coffeehouse, coronavirus disease 2019, diesel fuel, distillation, dose (biochemistry), food, food and drug administration, hospital, ibuprofen, in vitro, innovation, laboratory, ligand (biochemistry), medication, molecule, nutraceutical, pain, pharmaceutical industry, pharmacokinetics, randomized controlled trial, red bull, solvent, starbucks, steam distillation, supercritical fluid, tetrahydrocannabinol, women's health
Austin Rhodus
Director Of Membership Services at Midwest Hemp Council
absorption (pharmacology), alternative medicine, anti-predator adaptation, appetite, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, dose (biochemistry), food, ligand (biochemistry), medication, nutraceutical, pain, red bull, solvent, starbucks, tetrahydrocannabinol
Daniel Sliva
CSO & Founder at DSTest Laboratories
allosteric regulation, anti-inflammatory, antiviral drug, aspirin, assay, attention, bioavailability, biology, blinded experiment, book, bootleg recording, brand, brand loyalty, breast cancer, cancer, cannabidiol, cannabidiol is, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cardiovascular disease, cell signaling, chemical substance, chemistry, chromatography, chronic pain, cigarette, clinical trial, clinicaltrials.gov, coffee, coffee bean, common sense, coronavirus disease 2019, crisis management, diesel fuel, dietary supplement, direct-to-consumer advertising, distillation, dose (biochemistry), drug, drug test, end-user, endocannabinoid system, experiment, first, pass effect, flax, food, food and drug administration, fraud, gastrointestinal tract, germination, good manufacturing practice, green tea, hemp, hepatotoxicity, high-performance liquid chromatography, hospital, ibuprofen, in vitro, infection, inflammation, innovation, insomnia, intravenous therapy, iso/iec 17025, knowledge, laboratory, ligand (biochemistry), lipid, marketplace, medication, melatonin, micro-encapsulation, mining, molecule, nabiximols, nanoparticle, national institutes of health, nutraceutical, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, organ transplantation, osteoarthritis, packaging and labeling, pain, paracetamol, peripheral neuropathy, petroleum, pharmaceutical industry, pharmacokinetics, pharmacology, psychoactive drug, randomized controlled trial, reason, receptor (biochemistry), recycling, reliability engineering, research, right to know, risk, route of administration, sense, serotonin, sleep disorder, social supports, steam distillation, steve jobs, supercritical fluid, taste, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, the end-user, thin-layer chromatography, toxicity, vitamin, warranty, waste, water, women's health
Blair Curless
Clinical Pharmacist at Phoebe Putney Health System
absorption (pharmacology), advertising, analgesic, anti-inflammatory, aphria (company), bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, class action, coffee, cosmetics, damages, dietary supplement, distribution (marketing), doctor of pharmacy, dose (biochemistry), drug, euphoria, false advertising, federal trade commission, flavor, food, food and drug administration, hemp, interleukin 17, kool-aid, law, lawsuit, ligand (biochemistry), marketplace, medical cannabis, medication, mountain dew, nestea, new drug application, nonsteroidal anti-inflammatory drug, novel food, opioid, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, pricing, product testing, recycling, regulatory compliance, retail, route of administration, shelf life, social media, soft drink, sublingual administration, tea, tetrahydrocannabinol, tetrahydrocannabivarin, toast (honor), topical medication
Liz Geisleman
Vice President at Rocky Mountain Reagents
advertising, anti-inflammatory, brand, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, class action, damages, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug, drug enforcement administration, false advertising, federal trade commission, food, food and drug administration, good manufacturing practice, hemp, instagram, law, lawsuit, license, linkedin, medical cannabis, medication, new drug application, nutraceutical, pharmaceutical industry, pharmacy, product testing, qr code, regulatory compliance, social media, target audience, terpene, tetrahydrocannabinol, youtube
Ryan McFarland
CEO at WhereZHemp
aphria (company), brand, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, coffee, convertible bond, cosmetics, crowdfunding, debenture, debt, delta-8-tetrahydrocannabinol, dietary supplement, discounting, distribution (marketing), dose (biochemistry), drug enforcement administration, financial capital, flavor, food, food and drug administration, good manufacturing practice, health claim, hemp, instagram, interest, interest rate, investment, investor, kool-aid, license, linkedin, marketplace, medical cannabis, mergers and acquisitions, mountain dew, nestea, novel food, nutraceutical, option (finance), organic certification, pharmaceutical industry, pharmacy, prescription drug, pricing, qr code, recycling, retail, shelf life, soft drink, stock, stock dilution, target audience, tea, terpene, tetrahydrocannabinol, toast (honor), valuation (finance), youtube
Ricky Chandler
Co-Founder at CBD WIILLY
cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug enforcement administration, food and drug administration, good manufacturing practice, hemp, instagram, license, linkedin, medical cannabis, nutraceutical, pharmaceutical industry, qr code, target audience, terpene, tetrahydrocannabinol, youtube
Rebecca Zirkle
Owner & Founder at Cultivate Hope Chemovar
cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug enforcement administration, food and drug administration, good manufacturing practice, hemp, instagram, license, linkedin, medical cannabis, nutraceutical, pharmaceutical industry, qr code, target audience, terpene, tetrahydrocannabinol, youtube
Daniel Tobon
Chief Executive Officer / Director at iVIK Holdings Ltd
absorption (pharmacology), anti-inflammatory, anticoagulant, anticonvulsant, antidepressant, anxiolytic, benzodiazepine, brand, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), certificate of analysis, clinical trial, convertible bond, cosmetics, crowdfunding, cytochrome p450, debenture, debt, democratic party (united states), dietary supplement, discounting, dose (biochemistry), drug interaction, drug overdose, entourage effect, financial capital, food and drug administration, geriatrics, gerrymandering, grapefruit–drug interactions, health claim, interest, interest rate, investment, investor, major depressive disorder, mechanism of action, medical cannabis, medication, mergers and acquisitions, neuroplasticity, neurotransmitter, opioid, option (finance), organic certification, over-the-counter drug, oxycodone/paracetamol, pharmacology, pharmacy, post-traumatic stress disorder, prescription drug, prothrombin time, psilocybin, psilocybin mushroom, psychedelic drug, pulmonary embolism, retail, sense, serotonin, signal transduction, stock, stock dilution, stroke, swing state, tetrahydrocannabinol, therapeutic index, valuation (finance), warfarin
Charles Piermarini
CEO at Restorative CBD
absorption (pharmacology), adoption, allosteric regulation, anti-inflammatory, anticoagulant, anticonvulsant, antiviral drug, benzodiazepine, bioavailability, breathing, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), certificate of analysis, clinical trial, coronavirus disease 2019, cytochrome p450, dietary supplement, dose (biochemistry), drug, drug interaction, drug overdose, flax, geriatrics, grapefruit–drug interactions, infection, inhaler, insomnia, ligand (biochemistry), lung volumes, medical cannabis, medication, melatonin, nanotechnology, omega-3 fatty acid, omega-6 fatty acid, opioid, over-the-counter drug, oxycodone/paracetamol, pain, patient, pharmaceutical industry, pharmacology, pharmacy, prothrombin time, pulmonary embolism, risk, route of administration, sense, serotonin, serotonin syndrome, signal transduction, sleep disorder, stroke, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, warfarin
Najifa Choudhury
Ambulatory Care Pharmacist at PACE SEMI
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis (drug), cannabis edible, certificate of analysis, clinical trial, cytochrome p450, doctor of pharmacy, dose (biochemistry), drug interaction, drug overdose, euphoria, geriatrics, grapefruit–drug interactions, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, opioid, over-the-counter drug, oxycodone/paracetamol, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, prothrombin time, pulmonary embolism, route of administration, signal transduction, stroke, sublingual administration, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Ronie Schmelz
Counsel at Tucker Ellis, LLP
advertising, anti-inflammatory, brand, budtender, cannabidiol, cannabis (drug), class action, damages, dietary supplement, dose (biochemistry), drug, false advertising, federal trade commission, food, food and drug administration, hemp, law, lawsuit, medical cannabis, medication, new drug application, pharmacy, product testing, regulatory compliance, social media
Jessica Arent
Chief Compliance Officer at Cannabidiol Life
advertising, anti-inflammatory, audience measurement, audit, avatar (computing), barcode, bioavailability, biodegradation, biomass, bioplastic, brand, budtender, candy, cannabidiol, cannabinoid, cannabis, cannabis (drug), carbon dioxide, certificate of analysis, certification, chernobyl disaster, class action, clinical trial, concept, controlled substances act, cosmetics, cotton, credibility, customer experience, damages, dietary supplement, don julio, dose (biochemistry), drug, economic development, emulsion, end user, false advertising, fda warning letter, federal trade commission, food, food and drug administration, generally recognized as safe, good manufacturing practice, graphic design, greenwashing, gummy candy, hemp, hydrophobe, ibuprofen, inbound marketing, instagram, internet, kashrut, landfill, law, lawsuit, linkedin, liquid, massage, medical cannabis, medicare (united states), medication, mind, new drug application, non-disclosure agreement, nonsteroidal anti-inflammatory drug, organic certification, over-the-counter drug, packaging and labeling, paracetamol, personal protective equipment, pesticide, petroleum, pharmaceutical industry, pharmacy, plastic bag, podcast, pricing, product testing, publicist, publishing, radio advertisement, recycling, regulatory compliance, shampoo, social media, social media marketing, social stigma, soil, solution, supply chain, sustainability, symbol, target corporation, target market, tax, testimonial, tetrahydrocannabinol, textile, tylenol (brand), understanding, vlog, washing machine, waste, water
Cohin Kakar
Chief Marketing Officer at The Anthos Group
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, appetite, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, certificate of analysis, chemotherapy, clinical trial, cytochrome p450, dementia, doctor of pharmacy, dose (biochemistry), drug development, drug interaction, drug overdose, euphoria, fibromyalgia, food and drug administration, geriatrics, grapefruit–drug interactions, headache, inflammation, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, opioid epidemic in the united states, over-the-counter drug, oxycodone/paracetamol, personalized medicine, pharmaceutical formulation, pharmacogenomics, pharmacology, pharmacy, pharmacy school, placebo, prothrombin time, pulmonary embolism, route of administration, sensitivity and specificity, signal transduction, stroke, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Lola O Ohonba
Certified Medical Cannabist Specialist at WCI Health
absorption (pharmacology), alternative medicine, analgesic, anti-inflammatory, anti-predator adaptation, antidepressant, anxiolytic, appetite, bioavailability, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, democratic party (united states), doctor of pharmacy, dose (biochemistry), entourage effect, euphoria, food, food and drug administration, gerrymandering, interleukin 17, ligand (biochemistry), major depressive disorder, mechanism of action, medical cannabis, medication, neuroplasticity, neurotransmitter, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pain, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, red bull, route of administration, sense, serotonin, solvent, starbucks, sublingual administration, swing state, tetrahydrocannabinol, tetrahydrocannabivarin, topical medication
Joseph Friedman
Consultant, National Speaker, Medical Cannabis Pharmacist
absorption (pharmacology), analgesic, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis strain, clinical trial, delta-8-tetrahydrocannabinol, doctor of pharmacy, dose (biochemistry), euphoria, first pass effect, high-performance liquid chromatography, institutional review board, interleukin 17, ligand (biochemistry), lipophilicity, mass spectrometry, medication, natural product, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, route of administration, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, topical medication, waters corporation
Jourdan Woltz
Owner at JADE Healing Co CBD
antidepressant, autism, belief, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis indica, cannabis sativa, cannabis strain, chromatography, dose (biochemistry), dronabinol, drug test, entourage effect, environmental remediation, ethanol, fertilizer, freeze-drying, health care, hexane, high-performance liquid chromatography, isopropyl alcohol, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, solution, substance dependence, supercritical carbon dioxide, supercritical fluid, tetrahydrocannabinol, treatment-resistant depression, water
Jorge A. Escudero
Pharmacist at CBD Apothecary
alzheimer's disease, antipsychotic, bipolar disorder, cannabidiol, cannabinoid, cannabis (drug), cannabis strain, certificate of analysis, depression (mood), dopamine, dose (biochemistry), emergency medical technician, hypertension, irritable bowel syndrome, medicine, norepinephrine, omega-6 fatty acid, paracetamol, parkinson's disease, pharmacology, placebo, post-traumatic stress disorder, prescription drug, serotonin, topical medication
Richard Harris
Founder at Great Health and Wellness
alzheimer's disease, antipsychotic, bipolar disorder, cannabidiol, cannabinoid, cannabis (drug), cannabis strain, certificate of analysis, depression (mood), dopamine, dose (biochemistry), emergency medical technician, hypertension, irritable bowel syndrome, medicine, norepinephrine, omega-6 fatty acid, paracetamol, parkinson's disease, pharmacology, placebo, post-traumatic stress disorder, prescription drug, serotonin, topical medication
Chip Paul
President & Co-Founder at GnuPharma
alternative medicine, alzheimer's disease, antidepressant, antipsychotic, appetite, autism, autoimmune disease, belief, bioavailability, bipolar disorder, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cattle feeding, certificate of analysis, chemotherapy, consumer protection, depression (mood), dietary supplement, docosahexaenoic acid, dopamine, dose (biochemistry), dronabinol, drug development, eating, eicosapentaenoic acid, emergency medical technician, emulsion, endocannabinoid system, endocrinology, epilepsy, fat, fibromyalgia, fish oil, food and drug administration, gpr55, health care, hormone, hunger (physiology), hypertension, hypothalamus, irritable bowel syndrome, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, nonverbal communication, norepinephrine, obesity, omega-3 fatty acid, omega-6 fatty acid, paracetamol, parkinson's disease, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, pharmacy, placebo, post-traumatic stress disorder, prescription drug, probiotic, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, serotonin, shelf life, sleep, substance dependence, synthetic cannabinoids, tablet (pharmacy), tetrahydrocannabinol, topical medication, traditional chinese medicine, treatment-resistant depression, triglyceride, trpv1, vitamin c, well-being
Israel Garcia
Director Of Chemistry at Bayou City Hemp Company
bioavailability, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, emulsion, endocannabinoid system, food and drug administration, health, human, ibuprofen, memory, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, route of administration, shelf life, sleep, solution, tablet (pharmacy), tetrahydrocannabinol, transparency and translucency
anti-inflammatory, antidepressant, aromatherapy, autism, behavior, belief, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, dose (biochemistry), drink, dronabinol, entourage effect, essential oil, health care, herbal distillate, hindsight bias, juice, lemon, limonene, major depressive disorder, management of depression, mango, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, secondary metabolite, selective serotonin reuptake inhibitor, spectrum, substance dependence, terpene, terpenoid, tetrahydrocannabinol, treatment-resistant depression, water, water activity
Annie Epley
Director of Operations at From Soil to Soul, LLC
anti-inflammatory, antidepressant, aromatherapy, autism, behavior, belief, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, dose (biochemistry), drink, dronabinol, entourage effect, essential oil, health care, herbal distillate, hindsight bias, juice, lemon, limonene, major depressive disorder, management of depression, mango, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, secondary metabolite, selective serotonin reuptake inhibitor, spectrum, substance dependence, terpene, terpenoid, tetrahydrocannabinol, treatment-resistant depression, water, water activity
Priscilla Agoncillo
Co-Founder at Original Breeders League
anti-inflammatory, antidepressant, anxiolytic, autism, belief, brand, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis industry, democratic party (united states), dispensary, dose (biochemistry), dravet syndrome, dronabinol, education, emergency medical technician, endocannabinoid system, entourage effect, epilepsy, food and drug administration, free market, gerrymandering, good manufacturing practice, hair loss, health care, major depressive disorder, management of depression, mdma, mechanism of action, medical cannabis, medication, medicine, mental disorder, mental health, mood stabilizer, neuroplasticity, neurotransmitter, paramedic, pediatrics, pharmaceutical industry, pharmacology, pharmacy, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychiatry, psychoactive drug, psychology, schizophrenia, selective serotonin reuptake inhibitor, sense, serotonin, substance dependence, swing state, syndrome, tetrahydrocannabinol, tony montana, treatment-resistant depression
Trey Tijerina
Owner at WhyPayTrey
advertising, antidepressant, audience measurement, audit, autism, avatar (computing), belief, blog, brand, brand awareness, cannabidiol, cannabinoid, cannabis, carbon dioxide, credibility, digital marketing, dose (biochemistry), dronabinol, facebook, false advertising, game balance, good manufacturing practice, google, google search, hashtag, health care, hemp, inbound marketing, instagram, internet, linkedin, major depressive disorder, management of depression, massage, mdma, medical cannabis, medicine, mental health, mood stabilizer, news, newspaper, pharmaceutical industry, pharmacy, podcast, product sample, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, publicist, publishing, radio advertisement, research, search engine optimization, selective serotonin reuptake inhibitor, small business, social media, social media marketing, social stigma, substance dependence, symbol, target market, testimonial, treatment-resistant depression, twitter, vlog, youtube
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anticoagulant, antipsychotic, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, budtender, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, certificate of analysis, depression (mood), dispensary, dopamine, dose (biochemistry), dravet syndrome, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, fibromyalgia, food and drug administration, free market, good manufacturing practice, gpr55, hair loss, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medicine, mental disorder, mental health, methotrexate, morphine, norepinephrine, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, pharmaceutical industry, pharmacology, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, randomized controlled trial, rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, serotonin, spasticities, sports medicine, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vaporizer (inhalation device), warfarin
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
1 2 3 4 5
1-30 of 145